Influenza A/B Antigen Detection Kit (Colloidal Gold Method)

INTENDED USE
Influenza A/B Antigen Detection Kit (Colloidal Gold Method) is a lateral flow immunoassay for the qualitative detection of Influenza A virus,and Influenza B virus in nasopharyngeal swab or saliva specimens. It is intended to be used as a screening test and provides a preliminary test result to aid in the diagnosis of Influenza A and B viral infections.
Any interpretation or use of this preliminary test result must also rely on other clinical findings as well as on the professional judgment of health care providers. Alternative test method(s) should be combined to confirm the test result obtained by this device.

Summary and explanation
Along with the common cold, influenza is one of the most common acute respiratory infections, producing symptoms such as headache, chills, dry cough, body aches and fever. The influenza A virus and influenza B virus are typically more prevalent and spreads around the world in seasonal epidemics resulting in hundreds of thousands of deaths worldwide annually and millions in pandemic years.The influenza A and influenza B diagnosis is difficult because the initial symptoms can be similar to those caused by other infectious agents. Because the influenza virus is highly contagious, accurate diagnosis and prompt treatment of patients can have a positive effect on public health. Accurate diagnosis and the ability to distinguish between A or B antigens can also help reduce the inappropriate use of antibiotics and gives the physician the opportunity to prescribe an antiviral therapy. Initiation of antiviral therapy should begin as soon as possible after onset, ideally within 48 hours of the appearance of symptoms, as treatment may reduce the duration of symptoms and hospitalization. Babio ® Influenza A/B Antigen Detection Kit(Colloidal Gold Method) can provide rapid detection of influenza A and/or B viral antigens from symptomatic patients.It can provides an instant test result in 15 minutes by minimally skilled personnel without the use of laboratory equipment.

TEST PROCEDURE
1. Open the packaging box, take out the inner package and let it equilibrate to room temperature.
2. Remove the test card from sealed pouch and use within 1 hour after opening. 3. Place the test card on a clean and level surface.
4. When testing the test strip, vertically immerse the test end of the test strip in the urine cup containing urine until the mark line is reached. After at least 3 seconds, take it out and place it on a flat surface.
5. When the test card is tested, use a straw to suck urine and add 2-3 drops to the sample port of the test card.
6. The start time, 5-15 minutes, 15 minutes after the decision is invalid.
Materials Provided

Specification: 1T/box,20T/box,25T/box,50T/box,100 T/box
RESULTS
1.NEGATIVE RESULT:
If only the C line develops, the test indicates that no detectable Influenza virus is present in the specimen. The result is negative or non-reactive.
2. POSITIVE RESULT:
2.1 In addition to the presence of the C line, if the T1 line develops, the test indicates the presence of Influenza A virus. The result is Influenza A positive or reactive.
2.2 In addition to the presence of the C line, if only the T2 line develops, the test indicates the presence of Influenza B virus. The result is Influenza B positive or reactive.
2.3 In addition to the presence of the C line, if both the T1 and T2 lines develop, the test indicates the presence of both Influenza A virus and Influenza B virus. The result is Influenza A and B positive or reactive.
3. INVALID
If the C line does not develop, the assay is invalid regardless of color development of the T line as indicated below. Repeat the assay with a new device.